COQ8A Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited human B lymphocyte population derived from the Raji Burkitt??s lymphoma cell line, featuring targeted disruption of the COQ8A gene. This polyclonal knockout pool provides a heterogeneous loss-of-function model that minimizes clonal biases, enabling robust interrogation of coenzyme Q10 (CoQ10) biology and mitochondrial function in a lymphoid cancer context. Unlike monoclonal derivatives, the polyclonal format captures population-level responses, ensuring experimental results are not artifacts of a single genomic clone.
The Raji cell line is an EBV-positive Burkitt??s lymphoma B lymphocyte model, widely employed in immunology and cancer research. Its transformed phenotype, driven by MYC translocation, imposes a high metabolic demand that is partly met by mitochondrial oxidative phosphorylation, thereby making it an ideal host to study COQ8A-dependent bioenergetic pathways. EBV-derived factors can further influence mitochondrial dynamics and apoptotic thresholds, adding translational relevance for lymphomagenesis studies.
COQ8A encodes an atypical kinase that localizes to the inner mitochondrial membrane and regulates the CoQ biosynthetic complex. It physically interacts with multiple COQ enzymes (COQ3, COQ4, COQ5, COQ6, COQ7, COQ9) and the co-chaperone HSPD1, facilitating CoQ10 production. Upstream regulators include the metabolic sensors AMPK and SIRT1, as well as the transcriptional regulators PPARGC1A (PGC-1??), NRF1, and TFAM, which coordinate mitochondrial biogenesis. Downstream, COQ8A activity is critical for the assembly and function of respiratory chain complexes I, II, and III, and it influences the expression of antioxidant proteins including SOD2 and CAT, thereby controlling ROS detoxification.
In Raji cells, COQ8A knockout disrupts CoQ10 synthesis, leading to impaired electron transport, reduced ATP output, and heightened oxidative stress. This mimics molecular hallmarks of primary CoQ10 deficiency and associated mitochondrial disorders, while also sensitizing cells to ferroptosis??a regulated cell death pathway driven by lipid peroxidation. The model therefore enables investigation of how B-cell lymphomas balance mitochondrial respiration and redox homeostasis, and whether CoQ10 dependency represents a targetable metabolic vulnerability in these malignancies.
Researchers can employ this model for HPLC-MS?Cbased CoQ10 quantification, western blotting of COQ complex components, and Seahorse respirometry to assess glycolytic and oxidative metabolism. Complementary assays include flow cytometric measurement of mitochondrial membrane potential (TMRE), ROS (DCFDA), and ferroptosis sensitivity (C11-BODIPY), as well as ATP luminescence and Annexin V apoptosis detection. These tools facilitate studies on mitochondrial dysfunction, drug screening for CoQ10 bypass therapies, and metabolic profiling of cancer cells with impaired respiration. For additional details and assay recommendations, contact Ascent Research.
